Norges Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $628M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $802M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.18B | Buy |
|
|||||
|
2024
Q1 | $1.06B | Buy |
|
|||||
|
2023
Q4 | $933M | Buy |
|
|||||
|
2023
Q3 | $871M | Buy |
|
|||||
|
2023
Q2 | $752M | Buy |
|
|||||
|
2023
Q1 | $823M | Buy |
|
|||||
|
2022
Q4 | $697M | Buy |
|
|||||
|
2022
Q3 | $625M | Buy |
|
|||||
|
2022
Q2 | $522M | Sell |
|
|||||
|
2022
Q1 | $690M | Buy |
|
|||||
|
2021
Q4 | $609M | Sell |
|
|||||
|
2021
Q3 | $593M | Sell |
|
|||||
|
2021
Q2 | $579M | Buy |
|
|||||
|
2021
Q1 | $464M | Sell |
|
|||||
|
2020
Q4 | $507M | Sell |
|
|||||
|
2020
Q3 | $656M | Sell |
|
|||||
|
2020
Q2 | $782M | Buy |
|
|||||
|
2020
Q1 | $401M | Buy |
|
|||||
|
2019
Q4 | $307M | Hold |
|
|||||
|
2019
Q3 | $227M | Hold |
|
|||||
|
2019
Q2 | $256M | Buy |
|
|||||
|
2019
Q1 | $329M | Buy |
|
|||||
|
2018
Q4 | $292M | Hold |
|
|||||
|
2018
Q3 | $316M | Sell |
|
|||||
|
2018
Q2 | $286M | Buy |
|
|||||
|
2018
Q1 | $284M | Buy |
|
|||||
|
2017
Q4 | $299M | Buy |
|
|||||
|
2017
Q3 | $338M | Sell |
|
|||||
|
2017
Q2 | $381M | Sell |
|
|||||
|
2017
Q1 | $304M | Sell |
|
|||||
|
2016
Q4 | $292M | Sell |
|
|||||
|
2016
Q3 | $305M | Buy |
|
|||||
|
2016
Q2 | $249M | Buy |
|
|||||
|
2016
Q1 | $252M | Sell |
|
|||||
|
2015
Q4 | $388M | Sell |
|
|||||
|
2015
Q3 | $350M | Buy |
|
|||||
|
2015
Q2 | $376M | Buy |
|
|||||
|
2015
Q1 | $324M | Buy |
|
|||||
|
2014
Q4 | $283M | Buy |
|
|||||
|
2014
Q3 | $242M | Sell |
|
|||||
|
2014
Q2 | $366M | Buy |
|
|||||
|
2014
Q1 | $193M | Buy |
|
|||||
|
2013
Q4 | $174M | Sell |
|
|||||
|
2013
Q3 | $216M | Buy |
|
|||||
|
2013
Q2 | $145M | Buy |
|